|
PRODUCTS
· Point of Care (POC) diagnostic · High throughput, multiplexed · Novel long-lifetime · Our current products in the Point of Care and high throughput, multiplexed genotyping business lines are not publically announced at this time. However, we will be pleased to discuss product targets of mutual interest with qualified partners, under non-disclosure agreement. Novel long lifetime phosphorescent nanoparticles are currently available for co-development, purchase or license. |


|
Personalized Medicine Molecular Diagnostics |


|
BioMedomics, Inc. 6 Davis Dr. Durham, NC 27709 P: 919.558.1210 F: 919.549.3599 |